The Persistent Challenge of Medical Implant Failures

Medical implants have revolutionized patient care, from artificial joints and surgical meshes to stents and breast reconstruction devices. Yet, for a significant number of patients, these life-improving technologies trigger chronic complications. Rates of issues like inflammation and fibrosis can reach 5% to 30% or higher for certain devices, leading to pain, deformity, and often costly revision surgeries. In Canada, where orthopedic and reconstructive procedures are common, thousands face these setbacks annually, highlighting an urgent need for better understanding and solutions.

Dalhousie's Breakthrough Study Reveals Immune System's Hidden Flaw

Researchers at Dalhousie University in Halifax, Nova Scotia, have pinpointed a key culprit in why implants fail: the immune system's misguided energy use. Published in Science Advances on December 17, 2025, the study "Persistent glycolysis defines pathological foreign body–associated inflammation to polymeric implants" uncovers how macrophages—the body's frontline immune cells—get trapped in a high-octane metabolic state called glycolysis near implants. Normally, these cells switch to a calmer oxidative phosphorylation mode after detecting no threat, promoting healing. But around foreign materials like polymers, they stay revved up, fueling endless inflammation and scar tissue formation.

Decoding the Metabolic Mismatch Driving Fibrosis

Glycolysis (glycolytic metabolism) is like a sprinter's burst of energy—fast but unsustainable for long hauls. In the Dalhousie study, led by PhD student Christian Rempe and Dr. Neal Callaghan under Dr. Locke Davenport Huyer, experiments showed macrophages upregulating glucose transporter 1 (GLUT1) right at the implant interface. This ramps up sugar uptake, boosting biosynthetic pathways for lipids and antioxidants, but sustains profibrotic signals. Spatial analysis confirmed higher GLUT1, lactate dehydrogenase A (LDHA), and mitochondrial markers closer to the implant, even in human breast implant revision tissues. Multinucleated giant cells, common in foreign body responses, were 80-95% glycolytic, worsening the cycle.

The Research Team: Dalhousie's Rising Stars in Biomaterials

Christian Rempe, a microbiology and immunology PhD candidate co-supervised by Dr. Michael Bezuhly (plastic surgery) and Dr. Davenport Huyer (Faculty of Dentistry), drove the metabolic profiling. Dr. Callaghan, a research assistant and internal medicine resident, contributed clinical insights. Dr. Davenport Huyer, assistant professor in Biomaterials & Applied Oral Sciences, Biomedical Engineering, and Microbiology & Immunology, leads the lab focused on immune-informed materials. Patient partners donated tissues, bridging lab and real-world needs. Funded by NSERC, CIHR, and Research Nova Scotia, this work exemplifies Dalhousie's interdisciplinary strength.

From Mouse Models to Human Tissues: Rigorous Methods Uncover Truths

The team implanted polyethylene (PE), polypropylene (PP), and polydimethylsiloxane (PDMS) discs subcutaneously in mice, harvesting tissues at 1, 3, and 6 weeks. Flow cytometry with SCENITH traced metabolic shifts, while immunofluorescence quantified markers like GLUT1 proximally (<30 μm from implant). Single-cell RNA sequencing linked Slc2a1-high (GLUT1) macrophages to wound healing genes (Fn1, Arg1, Vim). Human silicone breast reconstruction capsules mirrored findings, validating translation. These material-agnostic patterns point to universal foreign body response mechanisms.

Photo by Markus Winkler on Unsplash

• Early (1 week): 40-50% glycolytic macrophages
• Late (6 weeks): 60-80%, with biosynthetic upregulation
• Multinucleated cells: Largest, most glycolytic culprits

Real-World Impacts: Reducing Revisions and Improving Lives

In Canada, implant complications strain healthcare, with dental implants alone showing 2-3% failure rates in studies, higher for meshes in hernia repairs. Dalhousie's insights could slash revisions—10s of thousands yearly globally—by inspiring glycolysis-targeting coatings or drugs. For breast reconstruction post-cancer, fibrosis risks deformity; metabolic modulation promises smoother outcomes. Orthopedic joints and vascular stents stand to benefit too, cutting costs and pain.Read the full Science Advances paper

Atlantic Canada's Biomaterials Edge: Dalhousie at the Forefront

Dalhousie's School of Biomedical Engineering and Faculty of Dentistry concentrate expertise unmatched regionally. Unlike dispersed efforts elsewhere in Canada, Halifax hosts clinicians, engineers, and scientists ready to collaborate. Dr. Callaghan notes, "Innovation happens at intersections." This positions Atlantic Canada to lead safer implants, attracting talent and investment. For students eyeing research jobs in biomaterials, Dalhousie offers prime opportunities amid growing demand.

Pulse BioMed Hub: Catalyzing Regional Leadership

To harness this, Dalhousie proposes the Pulse BioMed Hub in the Life Sciences Research Institute. This shared space would unite disciplines for rapid prototyping, testing, and translation—from immune assays to 3D-printed devices. "A shared hub amplifies discoveries," says Rempe. Donor support could fund labs, drawing industry like Nova Scotia's medtech cluster. It aligns with Canada's biomaterials push, boosting economy and health.Learn more about Pulse BioMed Hub

Future Horizons: Therapies and Smarter Materials

Next steps: Probe foreign body giant cells, expand patient samples, and test glycolysis inhibitors. Biomaterials could embed metabolic nudges, shifting cells to healing modes. Dalhousie's lab eyes polyesters and drug deliveries. Broader: AI-driven designs, personalized implants. For aspiring researchers, career advice on academic CVs aids entry into fields like this.

Career Opportunities in Canada's Biomaterials Boom

This research spotlights higher ed roles in clinical research and engineering. Dalhousie seeks postdocs and faculty; check clinical research jobs or Canadian university jobs. Rate professors via Rate My Professor for insights. Atlantic Canada's hub potential means jobs in innovation hubs.

Photo by Markus Winkler on Unsplash

Toward Safer Implants: A Collaborative Path Forward

Dalhousie medical implants research illuminates why implants fail—persistent glycolysis trapping immune cells in inflammation. Atlantic Canada's leadership potential via hubs like Pulse BioMed promises global impact. Support research, explore higher ed jobs, university jobs, or career advice. Engage via comments below.